Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

The amyloid fibrils of the constant domain of immunoglobulin light chain.

Yamamoto K, Yagi H, Lee YH, Kardos J, Hagihara Y, Naiki H, Goto Y.

FEBS Lett. 2010 Aug 4;584(15):3348-53. doi: 10.1016/j.febslet.2010.06.019. Epub 2010 Jun 18.

2.

Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.

Staples GO, Shi X, Zaia J.

J Biol Chem. 2010 Jun 11;285(24):18336-43. doi: 10.1074/jbc.M110.101592. Epub 2010 Apr 2.

3.

Fibril protein fragmentation pattern in systemic AL-amyloidosis.

Enqvist S, Sletten K, Westermark P.

J Pathol. 2009 Dec;219(4):473-80. doi: 10.1002/path.2607.

PMID:
19771564
4.

Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway.

Motamedi-Shad N, Monsellier E, Torrassa S, Relini A, Chiti F.

J Biol Chem. 2009 Oct 23;284(43):29921-34. doi: 10.1074/jbc.M109.018747. Epub 2009 Aug 21.

5.

Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.

Elimova E, Kisilevsky R, Ancsin JB.

FASEB J. 2009 Oct;23(10):3436-48. doi: 10.1096/fj.09-134981. Epub 2009 Jun 23.

PMID:
19549924
6.

Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.

Lavatelli F, Perlman DH, Spencer B, Prokaeva T, McComb ME, Théberge R, Connors LH, Bellotti V, Seldin DC, Merlini G, Skinner M, Costello CE.

Mol Cell Proteomics. 2008 Aug;7(8):1570-83. doi: 10.1074/mcp.M700545-MCP200. Epub 2008 May 12.

7.

Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.

Connors LH, Jiang Y, Budnik M, Théberge R, Prokaeva T, Bodi KL, Seldin DC, Costello CE, Skinner M.

Biochemistry. 2007 Dec 11;46(49):14259-71. Epub 2007 Nov 16.

8.

Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.

Prokaeva T, Spencer B, Kaut M, Ozonoff A, Doros G, Connors LH, Skinner M, Seldin DC.

Arthritis Rheum. 2007 Nov;56(11):3858-68.

9.
10.

Role of endocytic inhibitory drugs on internalization of amyloidogenic light chains by cardiac fibroblasts.

Monis GF, Schultz C, Ren R, Eberhard J, Costello C, Connors L, Skinner M, Trinkaus-Randall V.

Am J Pathol. 2006 Dec;169(6):1939-52.

11.

Protein misfolding, functional amyloid, and human disease.

Chiti F, Dobson CM.

Annu Rev Biochem. 2006;75:333-66. Review.

PMID:
16756495
12.

The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein.

McLaughlin RW, De Stigter JK, Sikkink LA, Baden EM, Ramirez-Alvarado M.

Protein Sci. 2006 Jul;15(7):1710-22. Epub 2006 Jun 2.

14.

Heparin accelerates gelsolin amyloidogenesis.

Suk JY, Zhang F, Balch WE, Linhardt RJ, Kelly JW.

Biochemistry. 2006 Feb 21;45(7):2234-42.

15.

Cellular response of cardiac fibroblasts to amyloidogenic light chains.

Trinkaus-Randall V, Walsh MT, Steeves S, Monis G, Connors LH, Skinner M.

Am J Pathol. 2005 Jan;166(1):197-208.

16.

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.

Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG.

J Biol Chem. 2004 Nov 5;279(45):46363-6. Epub 2004 Sep 21.

17.

Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH.

Yamamoto S, Yamaguchi I, Hasegawa K, Tsutsumi S, Goto Y, Gejyo F, Naiki H.

J Am Soc Nephrol. 2004 Jan;15(1):126-33.

18.
19.

A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.

Khurana R, Ionescu-Zanetti C, Pope M, Li J, Nielson L, Ramírez-Alvarado M, Regan L, Fink AL, Carter SA.

Biophys J. 2003 Aug;85(2):1135-44.

20.

Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN.

Souillac PO, Uversky VN, Fink AL.

Biochemistry. 2003 Jul 8;42(26):8094-104.

PMID:
12834361

Supplemental Content

Support Center